BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063

Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of artificial intelligence-based precision small mole...

March 30, 2023 | Regulatory

Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows

Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...

March 29, 2023 | Influencers

Antengene Doses First Patient with ATG-022 for Advanced Solid Tumors in Australia

Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antig...

March 29, 2023 | News

Thermo Fisher Opens Cell Therapy Facility at UCSF to Advance Breakthrough Therapies.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | News

Berry Genomics and Ajlan & Bros Holdings Form Joint Venture to Support 'Vision 2030'

The joint venture will focus on genetic testing in the field of reproductive health and carry out in-depth collaboration on a series of projects that lever...

March 28, 2023 | News

BIORCHESTRA Strikes $861M Deal for CNS-Targeted Nanoparticle Delivery of Nucleic Acid Therapies

BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS) by leveragin...

March 28, 2023 | News

Everest Medicines receives full payment from Gilead for Trodelvy transaction, boosting cash reserves

"With the full upfront payment and other reimbursement from Gilead, we now have an even stronger balance sheet to advance development of products in our co...

March 28, 2023 | News

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

“We believe antibody therapies have an important role to play in protecting the most clinically at-risk populations from infectious diseases,” ...

March 24, 2023 | News

New Medium and Feeds System from Thermo Fisher Scientific Boosts CHO Cell Culture Performance

Thermo Fisher Scientific, a leading biotechnology company, recently provided expert insights into its new media and feed system, Gibco™ Effic...

March 21, 2023 | News

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

March 20, 2023 | News

Etana has secured financing from Deg, East Ventures and other global investors

Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production a...

March 20, 2023 | News

Keymed Biosciences Advancing Clinical Progress and Global Collaboration

Development of Innovative and Differentiated Pipelines Core Product CM310 (IL-4Rα antibody): Initiated Phase III registrational cl...

March 18, 2023 | News

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Ill...

March 15, 2023 | News

AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.

Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...

March 13, 2023 | News

Stay Connected